PEGS Boston Summit 2026
Boston, MA, USA
May 11–15, 2026
On May 11–15, 2026, meet us at Booth #418 for the 22nd Annual PEGS Boston Summit — the premier event shaping the future of biologics. Explore innovations in protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ML-driven biologics research.
Discover how Genedata solutions digitalize and automate R&D workflows for biotherapeutics and vaccines — covering screening, engineering, expression, purification, analysis, cell line development, bioprocess optimization, MS- and NGS-based quality control, and clinical trial design.
Join the talks below to learn how customers benefit from our solution.
Track: ML and Digital Integration in Biotherapeutic Analytics
KEYNOTE PRESENTATION: From Targets to Biologics: AI Powering the Next Leap in Discovery at Takeda
Yves Fomekong Nanfack, PhD, Head of AI/ML Research, Takeda
Monday, May 11 | 9:30 AM
Challenges in Digital Representation and Bioanalytical Characterization of Antibody-Drug Conjugates
Joel Bard, PhD, Research Fellow, Bioinformatics, BioMedicine Design, Pfizer
Monday, May 11 | 8:30 AM
Integrating Machine Learning and In-Silico Property Prediction into a Computational Workflow to Support CMC Development
Colin Stackhouse, Senior Scientist, Biologics Analytical Development, Johnson & Johnson Innovative Medicine
Monday, May 11 | 1:50 PM
Advancing Next-Generation Biotherapeutics: A Unified AI Platform for Developability Assessment
Jana Hersch, Head of Science, Genedata
Tuesday, May 12 | 10:05 AM
Track: Biophysical Methods
Automating MS Analytical Workflows for Novel Biologics
David Bush, PhD, Principal Scientist, Novartis Institutes for BioMedical Research
Wednesday, May 13 | 1:40 PM
Poster Presentations
Title: Harmonizing and Streamlining Chromatography and Electrophoresis Data Workflows with Genedata Chromatics
Poster: A050
Presenting author: Alyssa Lankone
Poster track: C6A: ML and Digital Integration in Biotherapeutic Analytics
Title: High‑Throughput Mass Spectrometry Analytics for ML/AI‑Ready Drug Discover
Poster: A049
Presenting author: Annie Goodstein
Poster track: C6A: ML and Digital Integration in Biotherapeutic Analytics
Title: A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates
Poster: C049
Presenting author: Chris Morgan
Poster track: C2C: Driving Clinical Success in Antibody‑Drug Conjugates
